Strakan gets better-than-expected boost from blue chip VCs

The UK pharmaceutical company has received a solid £30.5m from Warburg Pincus, 3i and LMS Group.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this